INDONESIAN JOURNAL OF PHARMACY
Vol 22 No 4, 2011

Sinergisitas efek sitotoksik kombinasi arekolin dan doxorubicin pada sel kanker serviks HeLa

Astrid Ayu Maruti (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada. Yogyakarta, Indonesia)
Rahmi Khamsita (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada. Yogyakarta, Indonesia)
Suven . (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada. Yogyakarta, Indonesia)
Dyaningtyas Dewi Putri (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada. Yogyakarta, Indonesia)
Edy Meiyanto (Faculty of Pharmacy, Universitas Gadjah Mada. Yogyakarta, Indonesia)



Article Info

Publish Date
01 Oct 2011

Abstract

Arecoline, the main alcaloid of Areca cathecuL has been proven to posses cytotoxic  activity  against  various  cancer  cell  lines.  The  research  conducted  to examine  the  cytotoxic  activity  of  arecoline  alone  and  its  combination  with doxorubicin  against  HeLa  cervical  cancer  cell  line.  Single treatment  of arecoline  in  various  concentration  on  HeLa  cancer  cell  were  done  followed  by the  combinational  treatment  with  doxorubicin.  The  cell  viability  as  the parameter  of  cytotoxicity  was  measured  using  MTT  (3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolium  bromide)  assay.  The  apoptotic  effect  was  examined  by double staining assay using etidium bromide – acridin orange. Arecoline did not show  potent  cytotoxicity  effect  against  HeLa  since  the  value  of  IC50 is  462µM. The  combinational  treatment  of  arecoline  and  doxorubicin  showed  synergicity with  the  optimum  CI  value  is  0,48  given  by  the  treatment  of  30mM  arecoline combined with 125 nM doxorubicin. The result of this study shows that arecoline has potential  to  be proposed  as  co-chemotherapeutic  agent for  cervical cancer. However, further study on its molecular mechanism needs to be conducted.Key words: arecoline, synergicity, doxorubicin, MTT assay, HeLa cell line

Copyrights © 2011






Journal Info

Abbrev

3

Publisher

Subject

Medicine & Pharmacology

Description

Indonesian Journal of Pharmacy (ISSN-e: 2338-9486, ISSN-p: 2338-9427), formerly Majalah Farmasi Indonesia (ISSN: 0126-1037). The journal had been established in 1972, and online publication was begun in 2008. Since 2012, the journal has been published in English by Faculty of Pharmacy Universitas ...